FDA Approves Tekturna HCT as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=640205&contenttype=newsarchive&channelID=26

Comments are closed.